Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS) — FY26 Annual Report | 8 September 2026

Aarey Drugs & Pharmaceuticals Ltd (AAREYDRUGS) filed its 2025-26 Annual Report on September 8, 2026, announcing the 36th AGM scheduled for September 30, 2026 via video conferencing. The report details financial performance showing revenue of ₹4,783.66 lakhs and profit of [amount context mismatch] lakhs for FY2025-26, with no dividend recommended. Key governance updates include reappointment of directors, related party transaction approvals totaling ₹15 crores with multiple entities, and compliance with SEBI regulations. The company maintains its Mumbai headquarters and lists shareholding details with promoters holding 37.71% stake. Risk disclosures highlight pending tax litigation, MSME dues of ₹18.31 lakhs, and CSR obligations of ₹11.64 lakhs unspent.